Japan Modifies Vow For Allowing OTC Drug Sales Via Internet
This article was originally published in PharmAsia News
Japan's government, which has vowed to deregulate Internet commerce, said it would retain limits on the sales of certain over-the-the counter drugs because of safety concerns.
You may also be interested in...
The submission of more trial data from Roche has prompted the US FDA to extend by three months its decision on whether to approve risdiplam for spinal muscular atrophy.
A temporary framework has been adopted by the European Commission that will allow companies and associations to co-ordinate efforts to tackle the coronavirus pandemic without raising competition concerns. The move has been welcomed by the European off-patent industry.
Germany’s family-owned Boehringer Ingelheim has supplemented its research efforts into finding COVID-19 therapies by supporting employees who volunteer to take part in COVID-19 relief efforts and by donating health care supplies, helped by a solid 2019 financial performance.